
1. curr opin hiv aids. 2010 jan;5(1):38-47. doi: 10.1097/coh.0b013e3283339b41.

improving first-line antiretroviral therapy resource-limited settings.

ford n(1), calmy a.

author information: 
(1)médecins sans frontières, medical unit, cape town, south africa.
nathan.ford@joburg.msf.org

purpose review: access first-line antiretroviral therapy in
resource-limited settings increased rapidly last 5 years. newer
medicines greater potency better safety profiles open possibility
for improving first-line antiretroviral therapy developing countries.
recent findings: several medicines offer potential improve simplicity,
safety efficacy first-line antiretroviral therapy resource-limited
settings. include tenofovir, raltegravir, elvitegravir, rilpivirine and
protease inhibitors. number clinical questions outstanding, particularly
regarding safety pregnancy compatibility drugs treat common
coinfections including tuberculosis.
summary: simple, affordable regimens key initial emergency response, 
but long-term response hiv calls reconsideration current
treatment options. preconditions widespread use developing countries
include affordability, simplicity answers relevant research questions. 
the absence strong pharmacovigilance systems, cohort monitoring be
critical assessing safety profile new drugs settings.

doi: 10.1097/coh.0b013e3283339b41 
pmid: 20046146  [indexed medline]

